Product Information
COLESTIPOL HCL 1 GM TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.6579 per EA under NDC 59762045001. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 19, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762045001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLESTIPOL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020222FDA Approved
7/19/1994
TE Code
AB
On Market Since
7/19/1994
Pharmacological Classes
Price Statistics
The NADAC for COLESTIPOL HCL 1 GM TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6579 per EA |
|---|---|
| All-time high | $0.9288 (Dec 14, 2016) |
| All-time low | $0.4912 (Jan 22, 2014) |
| 52-week high | $0.6835 |
| 52-week low | $0.6534 |
| Median price | $0.7495 |
| Average price | $0.7513 |
| Largest weekly change | +29.5% (Mar 19, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colestipol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESTIPOL HCL 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESTIPOL HCL 1 GM TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.6579 per EA (NDC 59762045001), effective Sep 30, 2026.
How has the price of COLESTIPOL HCL 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for COLESTIPOL HCL 1 GM TABLET has risen 33.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COLESTIPOL HCL 1 GM TABLET?
Since Nov 28, 2013, the NADAC for COLESTIPOL HCL 1 GM TABLET has ranged from a low of $0.4912 (Jan 22, 2014) to a high of $0.9288 (Dec 14, 2016), with a median of $0.7495 per EA.
Are there cheaper alternatives to COLESTIPOL HCL 1 GM TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as COLESTIPOL HCL 1 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COLESTIPOL HCL 1 GM TABLET?
COLESTIPOL HCL 1 GM TABLET (NDC 59762045001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.